Abstract P216 Table 1
NLCA dataLocal data
Male:female1.4:10.86:1
Histological confirmation68%89%
Stage IV at presentation in NSCLC32%55%
Active treatment received51%86%
Resection in NSCLC14%17%
Median NSCLC survival (day)232246